Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Autoimmune Disorders

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 166 articles:
HTML format



Single Articles


    May 2020
  1. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    PubMed    


  2. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    PubMed    


  3. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    PubMed    


  4. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    PubMed    


    April 2020
  5. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    PubMed    


  6. MORAND EF, Furie RA
    Anifrolumab in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2020;382:1666.
    PubMed    


  7. PUTMAN M
    Anifrolumab in Systemic Lupus Erythematosus.
    N Engl J Med. 2020;382:1665-1666.
    PubMed    


  8. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    PubMed    


  9. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    PubMed    


  10. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    PubMed    


    March 2020
  11. COOPER N, Ghanima W
    Immune Thrombocytopenia. Reply.
    N Engl J Med. 2020;382:1077-1078.
    PubMed    


  12. NOHRIA V, Macie AC
    Immune Thrombocytopenia.
    N Engl J Med. 2020;382:1077.
    PubMed    


  13. SOCAL MP, Greene JA
    Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.
    N Engl J Med. 2020;382:981-983.
    PubMed    


  14. BELLO F, Fagni F
    Nasal Deformity in Granulomatosis with Polyangiitis.
    N Engl J Med. 2020;382:951.
    PubMed    


    February 2020
  15. DEREBAIL VK, Falk RJ
    ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.
    N Engl J Med. 2020;382:671-673.
    PubMed    


  16. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    PubMed     Abstract available


  17. KOVATCHEV BP, Brown SA, Beck RW
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Reply.
    N Engl J Med. 2020;382:578.
    PubMed    


  18. ZUNIGA-HERNANDEZ JA, Medrano-De Avila C, Rodriguez-Gutierrez R
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577-578.
    PubMed    


  19. TAKITA M
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577.
    PubMed    


    January 2020
  20. DOUGLAS RS, Kahaly GJ, Patel A, Sile S, et al
    Teprotumumab for the Treatment of Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:341-352.
    PubMed     Abstract available


  21. SALMON JE, Niewold TB
    A Successful Trial for Lupus - How Good Is Good Enough?
    N Engl J Med. 2020;382:287-288.
    PubMed    


  22. AZAR MM, Muse VV, Villalba JA, Turbett SE, et al
    Case 2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
    N Engl J Med. 2020;382:276-285.
    PubMed    


  23. FASANO A, Leonard MM, Mitchell DM, Eng G, et al
    Case 1-2020: An 11-Year-Old Boy with Vomiting and Weight Loss.
    N Engl J Med. 2020;382:180-189.
    PubMed    


    December 2019
  24. MORAND EF, Furie R, Tanaka Y, Bruce IN, et al
    Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2019 Dec 18. doi: 10.1056/NEJMoa1912196.
    PubMed     Abstract available


    November 2019
  25. YAMAMURA T, Kleiter I, Fujihara K, Palace J, et al
    Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:2114-2124.
    PubMed     Abstract available


  26. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia. Reply.
    N Engl J Med. 2019;381:1881-1882.
    PubMed    


  27. SHVIDEL L, Stanevsky A, Sigler E
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:1881.
    PubMed    


  28. HEROLD KC, Bundy BN, Krischer JP
    Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply.
    N Engl J Med. 2019;381:1880-1881.
    PubMed    


  29. KORSGREN O, Skog O, Ludvigsson J
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879-1880.
    PubMed    


  30. COURI CE, Malmegrim KCR, Oliveira MC
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879.
    PubMed    


  31. ILANY J
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879.
    PubMed    


  32. SMITH C, Dhaliwal G, Saint S, Farkash EA, et al
    Double Trouble.
    N Engl J Med. 2019;381:1854-1860.
    PubMed    


    October 2019
  33. BRUTTOMESSO D
    Toward Automated Insulin Delivery.
    N Engl J Med. 2019;381:1774-1775.
    PubMed    


  34. FERVENZA FC, Cattran DC
    Rituximab or Cyclosporine for Membranous Nephropathy. Reply.
    N Engl J Med. 2019;381:1689-1690.
    PubMed    


  35. PONTICELLI C, Moroni G
    Rituximab or Cyclosporine for Membranous Nephropathy.
    N Engl J Med. 2019;381:1688-1689.
    PubMed    


  36. WALDMAN M, Austin HA 3rd, Balow JE
    Rituximab or Cyclosporine for Membranous Nephropathy.
    N Engl J Med. 2019;381:1688.
    PubMed    


  37. VALOTI E, Noris M, Remuzzi G
    More about Factor H Autoantibodies in Membranous Nephropathy.
    N Engl J Med. 2019;381:1590-1592.
    PubMed    


  38. LI J, Zhou Z
    Calcinosis in Juvenile Dermatomyositis.
    N Engl J Med. 2019;381:e31.
    PubMed    


  39. CHWALISZ BK, Buchbinder BR, Schmahmann JD, Samore WR, et al
    Case 32-2019: A 70-Year-Old Woman with Rapidly Progressive Ataxia.
    N Engl J Med. 2019;381:1569-1578.
    PubMed    


  40. BROWN SA, Kovatchev BP, Raghinaru D, Lum JW, et al
    Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2019 Oct 16. doi: 10.1056/NEJMoa1907863.
    PubMed     Abstract available


  41. TUNKEL AR, Baron EL, Buch KA, Marty FM, et al
    Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence.
    N Engl J Med. 2019;381:1459-1470.
    PubMed    


  42. MUSSO D, Ko AI, Baud D
    Zika Virus Infection - After the Pandemic.
    N Engl J Med. 2019;381:1444-1457.
    PubMed    


    September 2019
  43. SHARMA K, Patel A
    Livedo Reticularis in Cold Agglutinin Disease.
    N Engl J Med. 2019;381:e27.
    PubMed    


  44. COOPER N, Ghanima W
    Immune Thrombocytopenia.
    N Engl J Med. 2019;381:945-955.
    PubMed    


  45. TAZAWA R, Ueda T, Abe M, Tatsumi K, et al
    Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2019;381:923-932.
    PubMed     Abstract available


    August 2019
  46. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:647-654.
    PubMed    


  47. PITTOCK SJ, Berthele A, Fujihara K, Kim HJ, et al
    Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:614-625.
    PubMed     Abstract available


  48. CHIAPPA V, Anderson MA, Barrett CD, Stathatos N, et al
    Case 24-2019: A 39-Year-Old Woman with Palpitations, Abdominal Pain, and Vomiting.
    N Engl J Med. 2019;381:567-577.
    PubMed    


  49. CHARROW A, Vleugels RA
    Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2019;381:465.
    PubMed    


    July 2019
  50. CHEN Z, Wang X, Ye S
    Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
    N Engl J Med. 2019;381:291-293.
    PubMed    


  51. FREEMAN MW, Singh AK, Guidon AC, Arvikar SL, et al
    Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
    N Engl J Med. 2019;381:275-283.
    PubMed    


  52. DEUTSCHER S
    Phage Display to Detect and Identify Autoantibodies in Disease.
    N Engl J Med. 2019;381:89-91.
    PubMed    


  53. RUGGENENTI P, Remuzzi G
    A First Step toward a New Approach to Treating Membranous Nephropathy.
    N Engl J Med. 2019;381:86-88.
    PubMed    


  54. FERVENZA FC, Appel GB, Barbour SJ, Rovin BH, et al
    Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    N Engl J Med. 2019;381:36-46.
    PubMed     Abstract available


  55. LEE I, Walker JB, Nozaki K, Willett LL, et al
    Weak and Winded.
    N Engl J Med. 2019;381:76-82.
    PubMed    


    June 2019
  56. ROSEN CJ, Ingelfinger JR
    Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMe1907458.
    PubMed    


  57. HEROLD KC, Bundy BN, Long SA, Bluestone JA, et al
    An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
    PubMed     Abstract available


  58. BRAUN DA, Henderson GV, Sax PE, Miller AL, et al
    A Disturbing Decline.
    N Engl J Med. 2019;380:2257-2262.
    PubMed    


    May 2019
  59. ARVIKAR SL, Schoenfeld SR, Fox AS, Tanguturi VK, et al
    Case 17-2019: A 44-Year-Old Man with Joint Pain, Weight Loss, and Chest Pain.
    N Engl J Med. 2019;380:2157-2167.
    PubMed    


  60. BRAUN DA, Simchowitz B, Henderson GV, Sax PE, et al
    A Disturbing Decline.
    N Engl J Med. 2019;380:e42.
    PubMed    


  61. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    PubMed    


  62. IEZZONI LI
    Dangers of Diagnostic Overshadowing.
    N Engl J Med. 2019;380:2092-2093.
    PubMed    


  63. MONTALBAN X, Arnold DL, Weber MS, Staikov I, et al
    Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
    N Engl J Med. 2019 May 10. doi: 10.1056/NEJMoa1901981.
    PubMed     Abstract available


    April 2019
  64. ROGERS KK
    Diabetes and Disclosure.
    N Engl J Med. 2019;380:1495-1497.
    PubMed    


    March 2019
  65. HENDERSON CM, Fink SL, Bassyouni H, Argiropoulos B, et al
    Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
    N Engl J Med. 2019;380:1150-1157.
    PubMed     Abstract available


    December 2018
  66. SEIKRIT C, Ronco P, Debiec H
    Factor H Autoantibodies and Membranous Nephropathy.
    N Engl J Med. 2018;379:2479-2481.
    PubMed    


  67. LEFEBVRE DR, Reinshagen KL, Yoon MK, Stone JH, et al
    Case 39-2018: An 18-Year-Old Man with Diplopia and Proptosis of the Left Eye.
    N Engl J Med. 2018;379:2452-2461.
    PubMed    


  68. RICE GI, Meyzer C, Bouazza N, Hully M, et al
    Reverse-Transcriptase Inhibitors in the Aicardi-Goutieres Syndrome
    N Engl J Med. 2018;379:2275-7.
    PubMed    


    November 2018
  69. MARCHAND L
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970.
    PubMed    


  70. LAL A, Katta SR, Trivedi N
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970.
    PubMed    


  71. BALLY L, Thabit H, Hovorka R
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970-1971.
    PubMed    


  72. DOWNING NS, McMullan CJ, Rennke HG, Levy BD, et al
    Complements from the Lung.
    N Engl J Med. 2018;379:1767-1773.
    PubMed    


    September 2018
  73. LACKNER KJ, MullerCalleja N
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1290.
    PubMed    


  74. RIERA-MESTRE A, Vidaller A
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289-90.
    PubMed    


  75. CIAVARELLA A, Martinelli I
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289.
    PubMed    



  76. Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289-1290.
    PubMed    


  77. MANDAL J, Margaretten M
    Tuberculosis of the Finger.
    N Engl J Med. 2018;379:1161.
    PubMed    


  78. ANTEL J
    Therapy in Multiple Sclerosis - Coming of Age.
    N Engl J Med. 2018;379:1085-1086.
    PubMed    


  79. CHITNIS T, Arnold DL, Banwell B, Bruck W, et al
    Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    N Engl J Med. 2018;379:1017-1027.
    PubMed     Abstract available


    August 2018
  80. FOX RJ, Coffey CS, Conwit R, Cudkowicz ME, et al
    Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    N Engl J Med. 2018;379:846-855.
    PubMed     Abstract available


  81. GORMAN MP, Gombolay GY, Mehan WA Jr, Thibert RL, et al
    Case 27-2018: A 3-Year-Old Boy with Seizures.
    N Engl J Med. 2018;379:870-878.
    PubMed    


  82. FALK RJ, Husseini JS, Fenves AZ, Rosales IA, et al
    Case 24-2018: A 71-Year-Old Man with Acute Renal Failure and Hematuria.
    N Engl J Med. 2018;379:568-578.
    PubMed    


    June 2018
  83. SEPE V, Velluzzi F, Songini M
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2543.
    PubMed    


  84. YANAI H
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2542-3.
    PubMed    


  85. TRUFFAUT L, Lefebvre P
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2018;378:2517.
    PubMed    



  86. Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2542-2544.
    PubMed    


  87. ROSENBAUM JT, Silverman GJ
    The Microbiome and Systemic Lupus Erythematosus.
    N Engl J Med. 2018;378:2236-2237.
    PubMed    


    May 2018
  88. MORRIS CA, Patel MJ, Fenves AZ, Masia R, et al
    Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain.
    N Engl J Med. 2018;378:2124-2132.
    PubMed    


  89. GARCIA D, Erkan D
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;378:2010-2021.
    PubMed    


    March 2018
  90. HUSEBYE ES, Anderson MS, Kampe O
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:1132-1141.
    PubMed    


  91. KHOO TK, Olson KM
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:967.
    PubMed    


  92. DOUMAS M, Imprialos KP, Stavropoulos K
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:967.
    PubMed    


  93. CONTE C, Secchi A, Napoli N
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966.
    PubMed    


  94. GOGTAY NJ, Bose D, Thatte UM
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966.
    PubMed    



  95. Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966-968.
    PubMed    


  96. DALMAU J, Graus F
    Antibody-Mediated Encephalitis.
    N Engl J Med. 2018;378:840-851.
    PubMed    


  97. CASEY JD, Englert JA, Katz JT, Miller AL, et al
    An Unexpected Expectoration.
    N Engl J Med. 2018;378:853-858.
    PubMed    


    February 2018
  98. KNUESEL SJ, Guseh JS 2nd, Karp Leaf R, Ciaranello AL, et al
    Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia.
    N Engl J Med. 2018;378:753-760.
    PubMed    


  99. FLYNN JT
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:580.
    PubMed    


  100. MEI ZB, Xiao Y
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579.
    PubMed    


  101. JONNALAGADDA VG, Metety VK
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579.
    PubMed    



  102. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579-581.
    PubMed    


    January 2018
  103. CESTARI DM, Cunnane ME, Rizzo JF 3rd, Stone JH, et al
    Case 2-2018. A 41-Year-Old Woman with Vision Disturbances and Headache.
    N Engl J Med. 2018;378:282-289.
    PubMed    


  104. REICH DS, Lucchinetti CF, Calabresi PA
    Multiple Sclerosis.
    N Engl J Med. 2018;378:169-180.
    PubMed    


    December 2017
  105. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed    


    November 2017
  106. GHIASI M
    Strawberry Gingivitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;377:2073.
    PubMed    


  107. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed    


  108. MARCOVECCHIO ML, Chiesa ST, Bond S, Daneman D, et al
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2017;377:1733-1745.
    PubMed     Abstract available


    October 2017
  109. PALAMARA K, Nagarur A, Fintelmann FJ, Kohler MJ, et al
    Case 32-2017. A 64-Year-Old Man with Dyspnea, Wheezing, Headache, Cough, and Night Sweats.
    N Engl J Med. 2017;377:1569-1578.
    PubMed    


  110. AKIYAMA M
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493-4.
    PubMed    


  111. GONZALES-GAY MA, Loricera J, Blanco R
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed    


  112. STONE JH, Klearman M, Collinson N
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1494-1495.
    PubMed    



  113. Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed    


  114. ROSENBAUM JT
    Celiac Disease and Autoimmunity - The Missing Ingredient.
    N Engl J Med. 2017;377:1489-1490.
    PubMed    


    September 2017
  115. BHATTACHARYYA RP, Flores EJ, Azar MM
    Case 30-2017. A 65-Year-Old Woman with Altered Mental Status, Bacteremia, and Acute Liver Failure.
    N Engl J Med. 2017;377:1274-1282.
    PubMed    


  116. NATHAN DM
    Adjunctive Treatments for Type 1 Diabetes.
    N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMe1711296.
    PubMed    


  117. GARG SK, Henry RR, Banks P, Buse JB, et al
    Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
    N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMoa1708337.
    PubMed     Abstract available


  118. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
    Connecting the Dots.
    N Engl J Med. 2017;377:978-984.
    PubMed    


    August 2017
  119. PENG S, Sun X, Sun M
    Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;377:789.
    PubMed    



  120. Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;377:789-790.
    PubMed    


  121. METZ LM, Eliasziw M
    Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:789.
    PubMed    



  122. Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:788-789.
    PubMed    


  123. DIVAKARAN S, Dellaripa P, Kobzik L, Levy B, et al
    All That Wheezes....
    N Engl J Med. 2017;377:477-484.
    PubMed    


    July 2017
  124. HALLER M, Atkinson M, Schatz D
    More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403.
    PubMed    


  125. HELLMANN DB
    Giant-Cell Arteritis - More Ecstasy, Less Agony.
    N Engl J Med. 2017;377:385-386.
    PubMed    



  126. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403-5.
    PubMed    


  127. STONE JH, Tuckwell K, Dimonaco S, Klearman M, et al
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:317-328.
    PubMed     Abstract available



  128. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:405.
    PubMed    


  129. DIVAKARAN S, Vaidya A, Kobzik L, Dellaripa P, et al
    All That Wheezes...
    N Engl J Med. 2017;377:e6.
    PubMed    



  130. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed    


  131. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    PubMed    



  132. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed    


  133. NATHAN DM, Bebu I, Lachin JM
    Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:195.
    PubMed    



  134. Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:194-195.
    PubMed    


  135. KUMAR S, Sharma VK
    Unmasking Ptosis in Both Eyes.
    N Engl J Med. 2017;377:e1.
    PubMed    


    June 2017
  136. XIA Z, Friedlander RM
    Minocycline in Multiple Sclerosis - Compelling Results but Too Early to Tell.
    N Engl J Med. 2017;376:2191-2193.
    PubMed    


  137. METZ LM, Li DKB, Traboulsee AL, Duquette P, et al
    Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;376:2122-2133.
    PubMed     Abstract available


    May 2017
  138. ESFAHANI K, Miller WH Jr
    Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    N Engl J Med. 2017;376:1989-91.
    PubMed    


  139. WECHSLER ME, Akuthota P, Jayne D, Khoury P, et al
    Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;376:1921-1932.
    PubMed     Abstract available


  140. DJUKANOVIC R, O'Byrne PM
    Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;376:1985-1986.
    PubMed    


  141. BAIDAL DA, Ricordi C, Berman DM, Alvarez A, et al
    Bioengineering of an Intraabdominal Endocrine Pancreas.
    N Engl J Med. 2017;376:1887-1889.
    PubMed    



  142. Randomized Trial of Thymectomy in Myasthenia Gravis.
    N Engl J Med. 2017 May 4. doi: 10.1056/NEJMx170003.
    PubMed    


  143. SMITH TJ, Kahaly GJ, Ezra DG, Fleming JC, et al
    Teprotumumab for Thyroid-Associated Ophthalmopathy.
    N Engl J Med. 2017;376:1748-1761.
    PubMed     Abstract available


  144. RAMSEY BW, Nepom GT, Lonial S
    Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    N Engl J Med. 2017;376:1762-1769.
    PubMed    


    April 2017
  145. DEISENHAMMER F, Auer M, Hegen H
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693-4.
    PubMed    


  146. MILDINER S, Malnick S
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692-3.
    PubMed    


  147. SHARP MK
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692.
    PubMed    


  148. STERI M, Orru V, Idda ML, Pitzalis M, et al
    Overexpression of the Cytokine BAFF and Autoimmunity Risk.
    N Engl J Med. 2017;376:1615-1626.
    PubMed     Abstract available


  149. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    PubMed    


  150. MONTALBAN X, Belachew S, Wolinsky JS
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed    


  151. SCHOERGENHOFER C, Jilma B
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693.
    PubMed    


  152. HAUSER SL, Belachew Sh, Kappos L
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed    


  153. RAMANAN AV, Dick AD, Jones AP, McKay A, et al
    Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;376:1637-1646.
    PubMed     Abstract available


  154. THORNE JE
    Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;376:1682-1683.
    PubMed    



  155. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed     Abstract available


  156. INGELFINGER JR, Jarcho JA
    Increase in the Incidence of Diabetes and Its Implications.
    N Engl J Med. 2017;376:1473-1474.
    PubMed    


  157. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
    Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;376:1419-1429.
    PubMed     Abstract available


  158. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Abstract available


  159. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed    


  160. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
    Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
    PubMed     Abstract available


    March 2017
  161. MIRANDA S, Reid DK, John ChS
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  162. PRIOLA AM, Veltri A, Priola SM
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  163. INDRARATNA P, Matar W
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  164. GILHUS NE
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  165. DE OLIVEIRA WK, Carmo EH, Henriques CM, Coelho G, et al
    Zika Virus Infection and Associated Neurologic Disorders in Brazil.
    N Engl J Med. 2017 Mar 29. doi: 10.1056/NEJMc1608612.
    PubMed    


  166. NAGARUR A, Axelrod L, Dighe AS
    Case 9-2017. A 27-Year-Old Woman with Nausea, Vomiting, Confusion, and Hyponatremia.
    N Engl J Med. 2017;376:1159-1167.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: